Cyress 10 (barnidipine hydrochloride)

Cyress is a pharmaceutical product containing barnidipine hydrochloride, a calcium channel blocker used primarily for treating hypertension. The brand was originally developed by the Japanese pharmaceutical company Yamanouchi Pharmaceutical, which later merged to become Astellas Pharma.

In many European markets, including the Netherlands, the product is distributed by specialized pharmaceutical companies such as Bmodesto. While the original research and development took place in Japan, manufacturing for the European market often occurs across various certified pharmaceutical manufacturing sites within the European Union to meet local demand and regulatory standards. Astellas Pharma remains the ultimate owner of the brand's intellectual property globally.